chevron_leftBack
As of 5 June 2026, Panion & Bf Biotech Inc. has a market cap of $186.43M USD, ranking #21546 globally and #1007 in Taiwan.
It ranks #1934 in the Healthcare sector, and #700 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$186.43MUSD
5.86B TWD
Enterprise Value
$193.18MUSD
6.08B TWD
Revenue (TTM)
$65.59MUSD
2.06B TWD
EBITDA (TTM)
$13.42MUSD
422.29M TWD
Net Income (TTM)
$6.05MUSD
190.17M TWD
EBITDA Margin
20%
Profit Margin
9.2%
PE Ratio
31.0
PS Ratio
2.8
PB Ratio
3.0
EV/EBITDA
13.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Tsung-Ming Chiang
open_in_new
Founded
1976
Website
pbf.com.tw
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.3% | 5.7% | 7.6% | 1.8% | 3.6% | -3.3% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
1760
寶齡富錦生技股份有限公司
ISIN: TW0001760007
Shares Out.:
Shares Outstanding:
85.739M1
Shares Float:
67.817M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
68.20 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Panion & Bf Biotech Inc.
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6446
|
$7.8B
4K%
245.34B TWD
|
48.6
|
|
TWSE: 1795
|
$1.84B
888%
57.95B TWD
|
12.2
|
|
TPEX: 4123
|
$925.55M
396%
29.11B TWD
|
3.4
|
|
TPEX: 6535
|
$809.3M
334%
25.46B TWD
|
-
|
|
TPEX: 4743
|
$789.12M
323%
24.82B TWD
|
-
|
|
TPEX: 4105
|
$584.14M
213%
18.38B TWD
|
11.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
408K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
293K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
193K%
|
97.4
|
|
SIX: RO
|
$323.4B
173K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.25B
155K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$276.26B
148K%
218.9B CHF
|
20.5
|
chevron_leftBack